Orally given chemo-endocrine therapy for patients with luminal Her-2/neu negative metastasing breast cancer
Saved in:
Date: | 2016 |
---|---|
Main Authors: | Yu. O. Tymovska, O. S. Zotov, V. M. Pivniuk, M. F. Anikusko |
Format: | Article |
Language: | English |
Published: |
2016
|
Series: | Oncology |
Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000490853 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
-
Surgery features in the treatment of patients with HER2-neu positive breast cancer
by: I. Y. Halaichuk
Published: (2020) -
Results of mutation status gene HER-2/NEU in patients with breast cancer in Ukraine
by: B. T. Klimuk, et al.
Published: (2017) -
Impact of ASCO/CAP 2007, 2013 and 2018 recommendations on Her-2/neu gene amplification status testing in patients with breast cancer
by: B. T. Klimuk, et al.
Published: (2019) -
Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer
by: Shapochka, D.O., et al.
Published: (2012) -
Superroxide radicals: initiation of metastases in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2017)